Ardelyx Inc ARDX shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf offering of up to $250 million.
Ardelyx says the company intends to use the net proceeds, if any, from this offering for general corporate purposes, which may include, among other things, activities associated with the commercialization of IBSRELA and XPHOZAH, if approved, conducting post-approval pediatric clinical studies for IBSRELA and XPHOZAH, if approved and working capital.
See Also: Why Allstate Stock Is Hitting The Brakes Today
According to data from Benzinga Pro, ARDX has a 52-week high of $3.43 and a 52-week low of $0.49.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
